Actos Lawsuits | Actos Bladder Cancer

Ohio Plaintiff Sues Takeda for Bladder Cancer

Shay Morrigan | February 28th, 2012

Ohio resident James D. Mays filed one of many new Actos side effects lawsuits in the Circuit Court of Cook County, Illinois, on February 17, 2012. Mays claims to have suffered bladder cancer as a result of his ingestion of the diabetes drug, and is suing manufacturer Takeda Pharmaceuticals for damages. Mays claims he would not have used Actos had the defendants properly disclosed the risks of Actos side effects associated with long-term use.

Plaintiff claims bladder cancer after 6 years on the drug

Around April 2000, plaintiff Mays started taking Actos at the direction of his physician for the treatment of his type II diabetes. He claims that around April 2006, he was diagnosed with bladder cancer. As with other plaintiffs who have filed Actos lawsuits, Mays says he was unaware of the connection between the drug and such severe Actos side effects. He didn’t stop taking Actos until around July 2008.

Like others who have filed similar Actos lawsuits, Mays claims he will require ongoing medical care and treatment, that he has suffered severe mental and physical pain. He also claims that he has experienced economic loss because of medical expenses and related living expenses due to his new lifestyle.

Plaintiff claims defendant failed to warn of Actos side effects

Many Actos lawsuits have blamed Takeda for failing to warn of bladder cancer.

Mays notes in his lawsuit the animal studies that showed a potential link between the drug and the disease which were conducted prior to the drug’s approval by the FDA in 1999. He notes other studies that also showed a link between Actos and bladder cancer, such as the 2005 PROactive three-year study.

Serious Actos side effects such as bladder cancer were not brought to the public’s attention until September 17, 2010, when the FDA issued a safety announcement stating it was undertaking a review of the data from an ongoing, ten-year epidemiological study. The five-year interim analysis demonstrated that the risk of cancer increases with increased dosage and duration of use.

On June 15, 2011, the FDA issued another safety announcement stating that the use of Actos for more than a year may be associated with an increased risk of bladder cancer.

Actos lawsuits consolidated in Louisiana

Because of the rising number of Actos lawsuits filed in federal courts around the nation, the U.S. Judicial Panel for Multidistrict Litigation recently consolidated these cases into one court in the Western District of Louisiana.

Most of these Actos lawsuits allege bladder cancer, but some detail other Actos side effects such as congestive heart failure and heart attack. In 2007, the FDA required a black box warning on Actos because of heart-related side effects.